In this Issue
Zsanett Bahor; Jing Liao; Malcolm R. Macleod; Alexandra Bannach-Brown; Sarah K. McCann; Kimberley E. Wever; James Thomas; Thomas Ottavi; David W. Howells; Andrew Rice; Sophia Ananiadou; Emily Sena
Clinical Science (1 October 2017) 131 (20): 2525–2532.
Understanding a role for hypoxia in lesion formation and location in the deep and periventricular white matter in small vessel disease and multiple sclerosis
Clinical Science (1 October 2017) 131 (20): 2503–2524.
Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR−/− mouse model of atherosclerosis
Dawn Thompson; Nicola Morrice; Louise Grant; Samantha Le Sommer; Emma K. Lees; Nimesh Mody; Heather M. Wilson; Mirela Delibegovic
Clinical Science (1 October 2017) 131 (20): 2489–2501.
Neutralization of either IL-17A or IL-17F is sufficient to inhibit house dust mite induced allergic asthma in mice
Pauline Chenuet; Louis Fauconnier; Fahima Madouri; Tiffany Marchiol; Nathalie Rouxel; Aurélie Ledru; Pascal Mauny; Rachel Lory; Catherine Uttenhove; Jacques van Snick; Yoichiro Iwakura; Franco di Padova; Valérie Quesniaux; Dieudonnée Togbe; Bernhard Ryffel
Clinical Science (1 October 2017) 131 (20): 2533–2548.
Cover ImageIn this issue of Clinical Science, Thompson et al (pages 2489-2501) describe their research on the capacity of protein tyrosine phosphatase 1B inhibitor to reverse atherosclerotic plaque formation in a mouse model. The cover image shows aortic root sections of mice fed on a high-fat-diet that are stained with Oil Red - a method the authors used to quantify plaque formation in this study.